J de Rooij
Papers
2
Total Citations
10
H-Index
2
About
J. de Rooij is a leading clinical researcher in urological oncology, with a focused expertise in bladder cancer surgery and comparative effectiveness research. Their major contributions center on evaluating the long-term oncological outcomes of robot-assisted radical cystectomy (RARC) versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer. Through landmark population-based studies using Dutch national data, de Rooij has provided critical evidence on intermediate-term survival outcomes, demonstrating that RARC offers comparable oncological safety to open surgery while potentially improving recovery. Their 2021 study on intermediate-term survival, cited 8 times, and a companion paper on overall survival have helped clarify the real-world effectiveness of robotic surgery in bladder cancer treatment. This work is particularly impactful for surgical decision-making, as it addresses the key question of whether minimally invasive approaches compromise cancer control. By leveraging large-scale registry data, de Rooij has contributed high-quality evidence that informs clinical guidelines and patient counseling. Their research bridges the gap between surgical innovation and evidence-based practice, making them a valuable voice in the ongoing debate over optimal surgical approaches for bladder cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2